ArticleAIDS (London, England)2021

Growing data for recycling tenofovir and lamivudine with dolutegravir as empiric second-line antiretroviral therapy in resource-limited settings.

Tafireyi Marukutira et al.PubMed ↗Publisher ↗

No numbers read from the abstract.